FDA to Require Labeling Content Submissions in SPL Format on Oct. 31

Drug Industry Daily
KEYWORDS FDA / Technology

Beginning at the end of the month, the FDA will require drugmakers to adopt the structured product language (SPL) format for certain human drug labeling submissions, according to an agency official.

To View This Article:


Subscribe To Drug Industry Daily